{"title":"慢性阻塞性肺疾病患者口服皮质类固醇的急诊重访率:一项观察性研究","authors":"T. Ismaeil","doi":"10.21786/bbrc/15.1.6","DOIUrl":null,"url":null,"abstract":"Studies report inconclusive results regarding the efficacy of oral corticosteroids to reduce the risk of re-visiting the Emergency Department (ED). The aim of this study was to compare COPD patients who received oral corticosteroids and got re -admitted to the ED earlier than 60 days. An observational study was conducted at the ED from 2016 to 2018. A cohort of adult COPD patients, who received oral corticosteroids was assessed for any ED re-visit due to a COPD exacerbation. A total of 325 COPD patients included the study, 71% had no subsequent ED visit, and 94 (28%) patients had a repeat ED visit due to a COPD exacerbation. Of this ED re-visit group, 61% was within 60 days. The ED re-visit within 60 days group was more likely to have cardiovascular disease than the group with an ED re-visit after 60 days (51% vs. 45%, p-value 0.64).The use of oral corticosteroids could potentially reduce the severity of COPD exacerbation and ED re-visits.","PeriodicalId":9156,"journal":{"name":"Bioscience Biotechnology Research Communications","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Emergency Department Revisit Rate of Chronic Obstructive Pulmonary Disease Patients On Oral Corticosteroids: An Observational Study\",\"authors\":\"T. Ismaeil\",\"doi\":\"10.21786/bbrc/15.1.6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Studies report inconclusive results regarding the efficacy of oral corticosteroids to reduce the risk of re-visiting the Emergency Department (ED). The aim of this study was to compare COPD patients who received oral corticosteroids and got re -admitted to the ED earlier than 60 days. An observational study was conducted at the ED from 2016 to 2018. A cohort of adult COPD patients, who received oral corticosteroids was assessed for any ED re-visit due to a COPD exacerbation. A total of 325 COPD patients included the study, 71% had no subsequent ED visit, and 94 (28%) patients had a repeat ED visit due to a COPD exacerbation. Of this ED re-visit group, 61% was within 60 days. The ED re-visit within 60 days group was more likely to have cardiovascular disease than the group with an ED re-visit after 60 days (51% vs. 45%, p-value 0.64).The use of oral corticosteroids could potentially reduce the severity of COPD exacerbation and ED re-visits.\",\"PeriodicalId\":9156,\"journal\":{\"name\":\"Bioscience Biotechnology Research Communications\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioscience Biotechnology Research Communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21786/bbrc/15.1.6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioscience Biotechnology Research Communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21786/bbrc/15.1.6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Emergency Department Revisit Rate of Chronic Obstructive Pulmonary Disease Patients On Oral Corticosteroids: An Observational Study
Studies report inconclusive results regarding the efficacy of oral corticosteroids to reduce the risk of re-visiting the Emergency Department (ED). The aim of this study was to compare COPD patients who received oral corticosteroids and got re -admitted to the ED earlier than 60 days. An observational study was conducted at the ED from 2016 to 2018. A cohort of adult COPD patients, who received oral corticosteroids was assessed for any ED re-visit due to a COPD exacerbation. A total of 325 COPD patients included the study, 71% had no subsequent ED visit, and 94 (28%) patients had a repeat ED visit due to a COPD exacerbation. Of this ED re-visit group, 61% was within 60 days. The ED re-visit within 60 days group was more likely to have cardiovascular disease than the group with an ED re-visit after 60 days (51% vs. 45%, p-value 0.64).The use of oral corticosteroids could potentially reduce the severity of COPD exacerbation and ED re-visits.